RevealDx Raises $3.4M Strategic Investment
Seattle-based RevealDx raises $3.4M in strategic funding from 4DMedical to expand the distribution of its AI-powered lung nodule diagnostic software.
RevealDx Raises $3.4M Strategic Investment
RevealDx, located in Seattle, Washington, is a healthcare technology company focused on AI-powered characterization of lung nodules. The company has secured $3.4 million in a strategic investment round from 4DMedical as part of a broader distribution partnership.
Investors
4DMedical, a global medical technology company specializing in respiratory care and advanced imaging, participated in this investment round.
RevealDx Use of Funds
The capital from this investment will be used to support the distribution of the company's flagship product, RevealAI-Lung, across the United States, Europe, Australia, and New Zealand.
About RevealDx
Founded to improve early cancer detection, RevealDx develops AI software designed to assist radiologists in characterizing lung nodules. Their primary product, RevealAI-Lung, provides a Malignancy Similarity Index score to help clinicians make informed diagnostic follow-up recommendations and has been validated across multiple patient cohorts.
Funding Details
Company Website: https://reveal-dx.com
Company: RevealDx
Raised: $3.4M
Round: Other
Funding Date: August 3, 2026
Lead Investor: 4DMedical
Company Website: https://reveal-dx.com/
Software Category: Healthcare AI
